APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mirabegron Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mirabegron Drugs Market Analysis and Forecast 2026-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchMirabegron Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Mirabegron Drugs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Mirabegron Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mirabegron Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Mirabegron Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Mirabegron Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mirabegron Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mirabegron Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mirabegron Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mirabegron Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Mirabegron Drugs include Alkem Laboratories, Astellas Pharma, Lupin Pharmaceuticals, Zydus Lifesciences, China Resources Pharmaceutical, Jiangsu Huayang Pharmaceutical, Jiangxi Shanxiang Pharmaceutical, Qilu Pharmaceutical and Shenzhen Main Luck Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Mirabegron Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mirabegron Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Mirabegron Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mirabegron Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mirabegron Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mirabegron Drugs sales, projected growth trends, production technology, application and end-user industry.

Mirabegron Drugs Segment by Company

Alkem Laboratories

Astellas Pharma

Lupin Pharmaceuticals

Zydus Lifesciences

China Resources Pharmaceutical

Jiangsu Huayang Pharmaceutical

Jiangxi Shanxiang Pharmaceutical

Qilu Pharmaceutical

Shenzhen Main Luck Pharmaceuticals

CSPC Pharmaceutical

Sichuan Gowell Pharmaceutical

Zhejiang Huayi Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Mirabegron Drugs Segment by Type

Extended-release Tablet

Oral Suspension

Mirabegron Drugs Segment by Application

Frequent Urination

Urgency

Urine Leakage

Other

Mirabegron Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mirabegron Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mirabegron Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mirabegron Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mirabegron Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mirabegron Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mirabegron Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mirabegron Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Extended-release Tablet Major Manufacturers Table 3. Oral Suspension Major Manufacturers Table 4. Global Mirabegron Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Frequent Urination Major Manufacturers Table 6. Urgency Major Manufacturers Table 7. Urine Leakage Major Manufacturers Table 8. Other Major Manufacturers Table 9. Mirabegron Drugs Industry Trends Table 10. Mirabegron Drugs Industry Drivers Table 11. Mirabegron Drugs Industry Opportunities and Challenges Table 12. Mirabegron Drugs Industry Restraints Table 13. Global Mirabegron Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Mirabegron Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Mirabegron Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Mirabegron Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Mirabegron Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Mirabegron Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Mirabegron Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Mirabegron Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Mirabegron Drugs Sales Market Share by Region (2021-2026) Table 22. Global Mirabegron Drugs Sales Market Share by Region (2027-2032) Table 23. Global Mirabegron Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Mirabegron Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Mirabegron Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Mirabegron Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Mirabegron Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Mirabegron Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Mirabegron Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Mirabegron Drugs Manufacturers, Product Type & Application Table 31. Global Mirabegron Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Mirabegron Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Mirabegron Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Mirabegron Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Mirabegron Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Mirabegron Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Mirabegron Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Mirabegron Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Mirabegron Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Mirabegron Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Mirabegron Drugs Sales Market Share by Type (2021-2026) Table 43. Global Mirabegron Drugs Sales Market Share by Type (2027-2032) Table 44. Global Mirabegron Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Mirabegron Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Mirabegron Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Mirabegron Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Mirabegron Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Mirabegron Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Mirabegron Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Mirabegron Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Mirabegron Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Mirabegron Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Mirabegron Drugs Sales Market Share by Application (2021-2026) Table 55. Global Mirabegron Drugs Sales Market Share by Application (2027-2032) Table 56. Global Mirabegron Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Mirabegron Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Alkem Laboratories Company Information Table 59. Alkem Laboratories Business Overview Table 60. Alkem Laboratories Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Alkem Laboratories Mirabegron Drugs Product Portfolio Table 62. Alkem Laboratories Recent Development Table 63. Astellas Pharma Company Information Table 64. Astellas Pharma Business Overview Table 65. Astellas Pharma Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Astellas Pharma Mirabegron Drugs Product Portfolio Table 67. Astellas Pharma Recent Development Table 68. Lupin Pharmaceuticals Company Information Table 69. Lupin Pharmaceuticals Business Overview Table 70. Lupin Pharmaceuticals Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Lupin Pharmaceuticals Mirabegron Drugs Product Portfolio Table 72. Lupin Pharmaceuticals Recent Development Table 73. Zydus Lifesciences Company Information Table 74. Zydus Lifesciences Business Overview Table 75. Zydus Lifesciences Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zydus Lifesciences Mirabegron Drugs Product Portfolio Table 77. Zydus Lifesciences Recent Development Table 78. China Resources Pharmaceutical Company Information Table 79. China Resources Pharmaceutical Business Overview Table 80. China Resources Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. China Resources Pharmaceutical Mirabegron Drugs Product Portfolio Table 82. China Resources Pharmaceutical Recent Development Table 83. Jiangsu Huayang Pharmaceutical Company Information Table 84. Jiangsu Huayang Pharmaceutical Business Overview Table 85. Jiangsu Huayang Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jiangsu Huayang Pharmaceutical Mirabegron Drugs Product Portfolio Table 87. Jiangsu Huayang Pharmaceutical Recent Development Table 88. Jiangxi Shanxiang Pharmaceutical Company Information Table 89. Jiangxi Shanxiang Pharmaceutical Business Overview Table 90. Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Product Portfolio Table 92. Jiangxi Shanxiang Pharmaceutical Recent Development Table 93. Qilu Pharmaceutical Company Information Table 94. Qilu Pharmaceutical Business Overview Table 95. Qilu Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Qilu Pharmaceutical Mirabegron Drugs Product Portfolio Table 97. Qilu Pharmaceutical Recent Development Table 98. Shenzhen Main Luck Pharmaceuticals Company Information Table 99. Shenzhen Main Luck Pharmaceuticals Business Overview Table 100. Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Product Portfolio Table 102. Shenzhen Main Luck Pharmaceuticals Recent Development Table 103. CSPC Pharmaceutical Company Information Table 104. CSPC Pharmaceutical Business Overview Table 105. CSPC Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. CSPC Pharmaceutical Mirabegron Drugs Product Portfolio Table 107. CSPC Pharmaceutical Recent Development Table 108. Sichuan Gowell Pharmaceutical Company Information Table 109. Sichuan Gowell Pharmaceutical Business Overview Table 110. Sichuan Gowell Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sichuan Gowell Pharmaceutical Mirabegron Drugs Product Portfolio Table 112. Sichuan Gowell Pharmaceutical Recent Development Table 113. Zhejiang Huayi Pharmaceutical Company Information Table 114. Zhejiang Huayi Pharmaceutical Business Overview Table 115. Zhejiang Huayi Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Zhejiang Huayi Pharmaceutical Mirabegron Drugs Product Portfolio Table 117. Zhejiang Huayi Pharmaceutical Recent Development Table 118. Chia Tai Tianqing Pharmaceutical Company Information Table 119. Chia Tai Tianqing Pharmaceutical Business Overview Table 120. Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Product Portfolio Table 122. Chia Tai Tianqing Pharmaceutical Recent Development Table 123. North America Mirabegron Drugs Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Mirabegron Drugs Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Mirabegron Drugs Sales by Type (2021-2026) & (K Units) Table 126. North America Mirabegron Drugs Sales by Type (2027-2032) & (K Units) Table 127. North America Mirabegron Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 128. North America Mirabegron Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 129. North America Mirabegron Drugs Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Mirabegron Drugs Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Mirabegron Drugs Sales by Application (2021-2026) & (K Units) Table 132. North America Mirabegron Drugs Sales by Application (2027-2032) & (K Units) Table 133. North America Mirabegron Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 134. North America Mirabegron Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 135. North America Mirabegron Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Mirabegron Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Mirabegron Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Mirabegron Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 139. North America Mirabegron Drugs Sales by Country (2021-2026) & (K Units) Table 140. North America Mirabegron Drugs Sales by Country (2027-2032) & (K Units) Table 141. North America Mirabegron Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 142. North America Mirabegron Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 143. United States Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 144. Canada Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 145. Mexico Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 146. Europe Mirabegron Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Mirabegron Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Mirabegron Drugs Sales by Type (2021-2026) & (K Units) Table 149. Europe Mirabegron Drugs Sales by Type (2027-2032) & (K Units) Table 150. Europe Mirabegron Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Europe Mirabegron Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Europe Mirabegron Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Mirabegron Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Mirabegron Drugs Sales by Application (2021-2026) & (K Units) Table 155. Europe Mirabegron Drugs Sales by Application (2027-2032) & (K Units) Table 156. Europe Mirabegron Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Europe Mirabegron Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Europe Mirabegron Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Mirabegron Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Mirabegron Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Mirabegron Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Europe Mirabegron Drugs Sales by Country (2021-2026) & (K Units) Table 163. Europe Mirabegron Drugs Sales by Country (2027-2032) & (K Units) Table 164. Europe Mirabegron Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Europe Mirabegron Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Germany Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 167. France Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 168. U.K. Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 169. Italy Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 170. Russia Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 171. Spain Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 174. Sweden Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 175. Poland Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 176. China Mirabegron Drugs Revenue by Type (2021-2026) & (US$ Million) Table 177. China Mirabegron Drugs Revenue by Type (2027-2032) & (US$ Million) Table 178. China Mirabegron Drugs Sales by Type (2021-2026) & (K Units) Table 179. China Mirabegron Drugs Sales by Type (2027-2032) & (K Units) Table 180. China Mirabegron Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 181. China Mirabegron Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 182. China Mirabegron Drugs Revenue by Application (2021-2026) & (US$ Million) Table 183. China Mirabegron Drugs Revenue by Application (2027-2032) & (US$ Million) Table 184. China Mirabegron Drugs Sales by Application (2021-2026) & (K Units) Table 185. China Mirabegron Drugs Sales by Application (2027-2032) & (K Units) Table 186. China Mirabegron Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 187. China Mirabegron Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 188. Asia Mirabegron Drugs Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Mirabegron Drugs Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Mirabegron Drugs Sales by Type (2021-2026) & (K Units) Table 191. Asia Mirabegron Drugs Sales by Type (2027-2032) & (K Units) Table 192. Asia Mirabegron Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 193. Asia Mirabegron Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 194. Asia Mirabegron Drugs Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Mirabegron Drugs Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Mirabegron Drugs Sales by Application (2021-2026) & (K Units) Table 197. Asia Mirabegron Drugs Sales by Application (2027-2032) & (K Units) Table 198. Asia Mirabegron Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 199. Asia Mirabegron Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Asia Mirabegron Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Mirabegron Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Mirabegron Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Mirabegron Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. Asia Mirabegron Drugs Sales by Country (2021-2026) & (K Units) Table 205. Asia Mirabegron Drugs Sales by Country (2027-2032) & (K Units) Table 206. Asia Mirabegron Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 207. Asia Mirabegron Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Japan Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 209. South Korea Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 210. India Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 211. Australia Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Mirabegron Drugs Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Mirabegron Drugs Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Mirabegron Drugs Sales by Type (2021-2026) & (K Units) Table 217. SAMEA Mirabegron Drugs Sales by Type (2027-2032) & (K Units) Table 218. SAMEA Mirabegron Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 219. SAMEA Mirabegron Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 220. SAMEA Mirabegron Drugs Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Mirabegron Drugs Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Mirabegron Drugs Sales by Application (2021-2026) & (K Units) Table 223. SAMEA Mirabegron Drugs Sales by Application (2027-2032) & (K Units) Table 224. SAMEA Mirabegron Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 225. SAMEA Mirabegron Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 226. SAMEA Mirabegron Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Mirabegron Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Mirabegron Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Mirabegron Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 230. SAMEA Mirabegron Drugs Sales by Country (2021-2026) & (K Units) Table 231. SAMEA Mirabegron Drugs Sales by Country (2027-2032) & (K Units) Table 232. SAMEA Mirabegron Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 233. SAMEA Mirabegron Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 234. Brazil Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 235. Argentina Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 236. Chile Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 237. Colombia Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 238. Peru Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 240. Israel Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 241. UAE Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 242. Turkey Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 243. Iran Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 244. Egypt Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Mirabegron Drugs Distributors List Table 248. Mirabegron Drugs Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Mirabegron Drugs Image Figure 2. Global Mirabegron Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mirabegron Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Extended-release Tablet Image Figure 5. Oral Suspension Image Figure 6. Global Mirabegron Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Mirabegron Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Frequent Urination Image Figure 9. Urgency Image Figure 10. Urine Leakage Image Figure 11. Other Image Figure 12. Global Mirabegron Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Mirabegron Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Mirabegron Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Mirabegron Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Mirabegron Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Mirabegron Drugs Sales (2021-2032) & (K Units) Figure 18. Global Mirabegron Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Mirabegron Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Mirabegron Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Mirabegron Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Mirabegron Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Mirabegron Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Mirabegron Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Mirabegron Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Mirabegron Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Mirabegron Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Mirabegron Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Mirabegron Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Mirabegron Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Mirabegron Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Mirabegron Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Mirabegron Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Mirabegron Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Mirabegron Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Mirabegron Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Mirabegron Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Mirabegron Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Mirabegron Drugs Revenue Share by Type (2021-2032) Figure 41. North America Mirabegron Drugs Sales Share by Type (2021-2032) Figure 42. North America Mirabegron Drugs Revenue Share by Application (2021-2032) Figure 43. North America Mirabegron Drugs Sales Share by Application (2021-2032) Figure 44. North America Mirabegron Drugs Revenue Share by Country (2021-2032) Figure 45. North America Mirabegron Drugs Sales Share by Country (2021-2032) Figure 46. Europe Mirabegron Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Mirabegron Drugs Sales Share by Type (2021-2032) Figure 48. Europe Mirabegron Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Mirabegron Drugs Sales Share by Application (2021-2032) Figure 50. Europe Mirabegron Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Mirabegron Drugs Sales Share by Country (2021-2032) Figure 52. China Mirabegron Drugs Revenue Share by Type (2021-2032) Figure 53. China Mirabegron Drugs Sales Share by Type (2021-2032) Figure 54. China Mirabegron Drugs Revenue Share by Application (2021-2032) Figure 55. China Mirabegron Drugs Sales Share by Application (2021-2032) Figure 56. Asia Mirabegron Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Mirabegron Drugs Sales Share by Type (2021-2032) Figure 58. Asia Mirabegron Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Mirabegron Drugs Sales Share by Application (2021-2032) Figure 60. Asia Mirabegron Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Mirabegron Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Mirabegron Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Mirabegron Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Mirabegron Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Mirabegron Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Mirabegron Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Mirabegron Drugs Sales Share by Country (2021-2032) Figure 68. Mirabegron Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Mirabegron Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Extended-release Tablet
  • Oral Suspension
Applications
  • Frequent Urination
  • Urgency
  • Urine Leakage
  • Other
Companies covered
  • Alkem Laboratories
  • Astellas Pharma
  • Lupin Pharmaceuticals
  • Zydus Lifesciences
  • China Resources Pharmaceutical
  • Jiangsu Huayang Pharmaceutical
  • Jiangxi Shanxiang Pharmaceutical
  • Qilu Pharmaceutical
  • Shenzhen Main Luck Pharmaceuticals
  • CSPC Pharmaceutical
  • Sichuan Gowell Pharmaceutical
  • Zhejiang Huayi Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mirabegron Drugs Market by Type
  3. 1.2.1 Global Mirabegron Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Extended-release Tablet
  5. 1.2.3 Oral Suspension
  6. 1.3 Mirabegron Drugs Market by Application
  7. 1.3.1 Global Mirabegron Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Frequent Urination
  9. 1.3.3 Urgency
  10. 1.3.4 Urine Leakage
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Mirabegron Drugs Market Dynamics
  1. 2.1 Mirabegron Drugs Industry Trends
  2. 2.2 Mirabegron Drugs Industry Drivers
  3. 2.3 Mirabegron Drugs Industry Opportunities and Challenges
  4. 2.4 Mirabegron Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mirabegron Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mirabegron Drugs Revenue by Region
  3. 3.2.1 Global Mirabegron Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mirabegron Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Mirabegron Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Mirabegron Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mirabegron Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mirabegron Drugs Sales by Region
  9. 3.4.1 Global Mirabegron Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mirabegron Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Mirabegron Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Mirabegron Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mirabegron Drugs Revenue by Manufacturers
  2. 4.1.1 Global Mirabegron Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mirabegron Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mirabegron Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mirabegron Drugs Sales by Manufacturers
  6. 4.2.1 Global Mirabegron Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mirabegron Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mirabegron Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mirabegron Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mirabegron Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mirabegron Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mirabegron Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Mirabegron Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mirabegron Drugs Market CR5 and HHI
  16. 4.8.2 2025 Mirabegron Drugs Tier 1, Tier 2, and Tier 3
5 Mirabegron Drugs Market by Type
  1. 5.1 Global Mirabegron Drugs Revenue by Type
  2. 5.1.1 Global Mirabegron Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mirabegron Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mirabegron Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mirabegron Drugs Sales by Type
  6. 5.2.1 Global Mirabegron Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mirabegron Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Mirabegron Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mirabegron Drugs Price by Type
6 Mirabegron Drugs Market by Application
  1. 6.1 Global Mirabegron Drugs Revenue by Application
  2. 6.1.1 Global Mirabegron Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mirabegron Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mirabegron Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mirabegron Drugs Sales by Application
  6. 6.2.1 Global Mirabegron Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mirabegron Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Mirabegron Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mirabegron Drugs Price by Application
7 Company Profiles
  1. 7.1 Alkem Laboratories
  2. 7.1.1 Alkem Laboratories Company Information
  3. 7.1.2 Alkem Laboratories Business Overview
  4. 7.1.3 Alkem Laboratories Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Alkem Laboratories Mirabegron Drugs Product Portfolio
  6. 7.1.5 Alkem Laboratories Recent Developments
  7. 7.2 Astellas Pharma
  8. 7.2.1 Astellas Pharma Company Information
  9. 7.2.2 Astellas Pharma Business Overview
  10. 7.2.3 Astellas Pharma Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Astellas Pharma Mirabegron Drugs Product Portfolio
  12. 7.2.5 Astellas Pharma Recent Developments
  13. 7.3 Lupin Pharmaceuticals
  14. 7.3.1 Lupin Pharmaceuticals Company Information
  15. 7.3.2 Lupin Pharmaceuticals Business Overview
  16. 7.3.3 Lupin Pharmaceuticals Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lupin Pharmaceuticals Mirabegron Drugs Product Portfolio
  18. 7.3.5 Lupin Pharmaceuticals Recent Developments
  19. 7.4 Zydus Lifesciences
  20. 7.4.1 Zydus Lifesciences Company Information
  21. 7.4.2 Zydus Lifesciences Business Overview
  22. 7.4.3 Zydus Lifesciences Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zydus Lifesciences Mirabegron Drugs Product Portfolio
  24. 7.4.5 Zydus Lifesciences Recent Developments
  25. 7.5 China Resources Pharmaceutical
  26. 7.5.1 China Resources Pharmaceutical Company Information
  27. 7.5.2 China Resources Pharmaceutical Business Overview
  28. 7.5.3 China Resources Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 China Resources Pharmaceutical Mirabegron Drugs Product Portfolio
  30. 7.5.5 China Resources Pharmaceutical Recent Developments
  31. 7.6 Jiangsu Huayang Pharmaceutical
  32. 7.6.1 Jiangsu Huayang Pharmaceutical Company Information
  33. 7.6.2 Jiangsu Huayang Pharmaceutical Business Overview
  34. 7.6.3 Jiangsu Huayang Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jiangsu Huayang Pharmaceutical Mirabegron Drugs Product Portfolio
  36. 7.6.5 Jiangsu Huayang Pharmaceutical Recent Developments
  37. 7.7 Jiangxi Shanxiang Pharmaceutical
  38. 7.7.1 Jiangxi Shanxiang Pharmaceutical Company Information
  39. 7.7.2 Jiangxi Shanxiang Pharmaceutical Business Overview
  40. 7.7.3 Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Product Portfolio
  42. 7.7.5 Jiangxi Shanxiang Pharmaceutical Recent Developments
  43. 7.8 Qilu Pharmaceutical
  44. 7.8.1 Qilu Pharmaceutical Company Information
  45. 7.8.2 Qilu Pharmaceutical Business Overview
  46. 7.8.3 Qilu Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Qilu Pharmaceutical Mirabegron Drugs Product Portfolio
  48. 7.8.5 Qilu Pharmaceutical Recent Developments
  49. 7.9 Shenzhen Main Luck Pharmaceuticals
  50. 7.9.1 Shenzhen Main Luck Pharmaceuticals Company Information
  51. 7.9.2 Shenzhen Main Luck Pharmaceuticals Business Overview
  52. 7.9.3 Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Product Portfolio
  54. 7.9.5 Shenzhen Main Luck Pharmaceuticals Recent Developments
  55. 7.10 CSPC Pharmaceutical
  56. 7.10.1 CSPC Pharmaceutical Company Information
  57. 7.10.2 CSPC Pharmaceutical Business Overview
  58. 7.10.3 CSPC Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CSPC Pharmaceutical Mirabegron Drugs Product Portfolio
  60. 7.10.5 CSPC Pharmaceutical Recent Developments
  61. 7.11 Sichuan Gowell Pharmaceutical
  62. 7.11.1 Sichuan Gowell Pharmaceutical Company Information
  63. 7.11.2 Sichuan Gowell Pharmaceutical Business Overview
  64. 7.11.3 Sichuan Gowell Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sichuan Gowell Pharmaceutical Mirabegron Drugs Product Portfolio
  66. 7.11.5 Sichuan Gowell Pharmaceutical Recent Developments
  67. 7.12 Zhejiang Huayi Pharmaceutical
  68. 7.12.1 Zhejiang Huayi Pharmaceutical Company Information
  69. 7.12.2 Zhejiang Huayi Pharmaceutical Business Overview
  70. 7.12.3 Zhejiang Huayi Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Zhejiang Huayi Pharmaceutical Mirabegron Drugs Product Portfolio
  72. 7.12.5 Zhejiang Huayi Pharmaceutical Recent Developments
  73. 7.13 Chia Tai Tianqing Pharmaceutical
  74. 7.13.1 Chia Tai Tianqing Pharmaceutical Company Information
  75. 7.13.2 Chia Tai Tianqing Pharmaceutical Business Overview
  76. 7.13.3 Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Product Portfolio
  78. 7.13.5 Chia Tai Tianqing Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Mirabegron Drugs Market Size by Type
  2. 8.1.1 North America Mirabegron Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Mirabegron Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Mirabegron Drugs Price by Type (2021-2032)
  5. 8.2 North America Mirabegron Drugs Market Size by Application
  6. 8.2.1 North America Mirabegron Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Mirabegron Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Mirabegron Drugs Price by Application (2021-2032)
  9. 8.3 North America Mirabegron Drugs Market Size by Country
  10. 8.3.1 North America Mirabegron Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mirabegron Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mirabegron Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Mirabegron Drugs Market Size by Type
  2. 9.1.1 Europe Mirabegron Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mirabegron Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Mirabegron Drugs Price by Type (2021-2032)
  5. 9.2 Europe Mirabegron Drugs Market Size by Application
  6. 9.2.1 Europe Mirabegron Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mirabegron Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Mirabegron Drugs Price by Application (2021-2032)
  9. 9.3 Europe Mirabegron Drugs Market Size by Country
  10. 9.3.1 Europe Mirabegron Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mirabegron Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mirabegron Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Mirabegron Drugs Market Size by Type
  2. 10.1.1 China Mirabegron Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Mirabegron Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Mirabegron Drugs Price by Type (2021-2032)
  5. 10.2 China Mirabegron Drugs Market Size by Application
  6. 10.2.1 China Mirabegron Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Mirabegron Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Mirabegron Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mirabegron Drugs Market Size by Type
  2. 11.1.1 Asia Mirabegron Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mirabegron Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Mirabegron Drugs Price by Type (2021-2032)
  5. 11.2 Asia Mirabegron Drugs Market Size by Application
  6. 11.2.1 Asia Mirabegron Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mirabegron Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Mirabegron Drugs Price by Application (2021-2032)
  9. 11.3 Asia Mirabegron Drugs Market Size by Country
  10. 11.3.1 Asia Mirabegron Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mirabegron Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mirabegron Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mirabegron Drugs Market Size by Type
  2. 12.1.1 SAMEA Mirabegron Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mirabegron Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mirabegron Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Mirabegron Drugs Market Size by Application
  6. 12.2.1 SAMEA Mirabegron Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mirabegron Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mirabegron Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Mirabegron Drugs Market Size by Country
  10. 12.3.1 SAMEA Mirabegron Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mirabegron Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mirabegron Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mirabegron Drugs Value Chain Analysis
  2. 13.1.1 Mirabegron Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mirabegron Drugs Production Mode & Process
  6. 13.2 Mirabegron Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mirabegron Drugs Distributors
  9. 13.2.3 Mirabegron Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst